Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 study evaluating adverse events and effectiveness of Gel Stent (XEN63) implantation using ab interno and ab externo approaches in adults with glaucoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Gel Stent (XEN63)

Snippet

Sponsor: AbbVie | Conditions: Primary Open Angle Glaucoma | Phase 3 | Status: RECRUITING